| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10920124 | Radiotherapy and Oncology | 2005 | 7 Pages |
Abstract
The results indicate that proton therapy for breast cancer can be cost-effective if appropriate risk groups are chosen as targets for the therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jonas Lundkvist, Mattias Ekman, Suzanne Rehn Ericsson, Ulf Isacsson, Bengt Jönsson, Bengt Glimelius,